(Q36536092)

14 August 2017

1 reference

title

The antimicrobial activity of mupirocin--an update on resistance (English)

1 reference

14 August 2017

The antimicrobial activity of mupirocin—an update on resistance (English)

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

28 October 2022

1 reference

B. Slocombe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684187

28 October 2022

C. Perry

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684187

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1684187

28 October 2022

publication date

1 September 1991

1 reference

full work available at URL

14 August 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:019567019190198H?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

https://api.elsevier.com/content/article/PII:019567019190198H?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

Journal of Hospital Infection

28 October 2022

published in

1 reference

14 August 2017

volume

19 Suppl B

1 reference

14 August 2017

page(s)

19-25

1 reference

Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase

14 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Echerichia coli by pseudomonic acid

28 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

Failure of mupirocin-resistant staphylococci to inactivate mupirocin.

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus.

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

Mechanism of mupirocin transport into sensitive and resistant bacteria

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

Staphylococcus aureus resistant to mupirocin

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

Transmissible mupirocin resistance in Staphylococcus aureus

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

Mupirocin-resistant Staphylococcus aureus

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

Mupirocin: a new topical antibiotic.

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

Mupirocin resistance in staphylococci

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

How does Pseudomonas fluorescens, the producing organism of the antibiotic pseudomonic acid A, avoid suicide?

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0195-6701(91)90198-H

28 October 2022

Identifiers

1 reference

14 August 2017

1 reference